TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test
Welcome to DNA Labs UAE, where we offer the TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test. This test is designed to identify mutations or variations in the TRAPPC9 gene that may be associated with mental retardation, autosomal dominant type 13 (MRD13).
Test Details
The TRAPPC9 gene is linked to MRD13, a genetic condition characterized by intellectual disability. Our NGS (Next-Generation Sequencing) technology allows us to analyze the DNA sequence of an individual’s genes and detect any variations or mutations that may be causing the intellectual disability.
By performing this genetic test, we can confirm a diagnosis, provide information about the specific genetic cause of the condition, and guide appropriate medical management and genetic counseling for affected individuals and their families.
Test Components
- Test Name: TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MRD13.
Please note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, such as genetic counselors or medical geneticists. They can provide more detailed information about the specific implications and limitations of the test, as well as the potential benefits and risks associated with genetic testing.
Test Name | TRAPPC9 Gene Mental retardation autosomal dominant type 13 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TRAPPC9 Gene Mental retardation, autosomal dominant type 13 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TRAPPC9 Gene Mental retardation, autosomal dominant type 13 |
Test Details |
The TRAPPC9 gene is associated with mental retardation, autosomal dominant type 13 (MRD13), which is a genetic condition characterized by intellectual disability. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes to identify any variations or mutations that may be associated with a particular condition. In the case of MRD13, NGS genetic testing can be used to identify any mutations or variations in the TRAPPC9 gene that may be causing the intellectual disability. This type of testing can help in confirming a diagnosis, providing information about the specific genetic cause of the condition, and guiding appropriate medical management and genetic counseling for affected individuals and their families. It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, such as genetic counselors or medical geneticists. They can provide more detailed information about the specific implications and limitations of the test, as well as the potential benefits and risks associated with genetic testing. |